A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes

ABSTRACT: Oral semaglutide (Rybelsus(®)) is a glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with 94% homology to human GLP-1. It is the first GLP-1RA developed for oral administration, and it comprises a co-formulation of the peptide semaglutide with the absorption enhancer sodium N-(8-...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Andreas, Knop, Filip Krag, Vilsbøll, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217049/
https://www.ncbi.nlm.nih.gov/pubmed/33964002
http://dx.doi.org/10.1007/s40265-021-01499-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217049/
https://www.ncbi.nlm.nih.gov/pubmed/33964002
http://dx.doi.org/10.1007/s40265-021-01499-w

Ejemplares similares